financetom
Business
financetom
/
Business
/
Blue Owl, Crusoe, Primary Digital Form $3.4 Billion JV for AI Data Center Development in Texas
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Blue Owl, Crusoe, Primary Digital Form $3.4 Billion JV for AI Data Center Development in Texas
Oct 15, 2024 10:14 AM

08:57 AM EDT, 10/15/2024 (MT Newswires) -- Blue Owl Capital (OWL), Crusoe Energy Systems, and Primary Digital Infrastructure formed a $3.4 billion joint venture to finance artificial intelligence data center capacity at the Lancium Clean Campus in Abilene, Texas, the companies said Tuesday.

Under the terms, Blue Owl's real estate platform and Primary Digital will jointly sponsor the 206 megawatts data center being designed, constructed, and operated by Crusoe, the companies added.

Crusoe will provide more than 200 megawatts of capacity next year, according to the companies.

Price: 21.73, Change: +0.07, Percent Change: +0.32

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
La-Z-Boy Misses Q1 Earnings, Revenue Estimates, Issues Soft Guidance, Shares Tumble
La-Z-Boy Misses Q1 Earnings, Revenue Estimates, Issues Soft Guidance, Shares Tumble
Aug 20, 2025
La-Z-Boy Inc ( LZB ) shares are tanking on Tuesday after the company reported financial results for the first quarter of fiscal 2026 after the market close. Here's a rundown of the report. See the continuing LZB story here. Q1 Highlights: La-Z-Boy ( LZB ) reported first-quarter revenue of $492.22 million, missing analyst estimates of $494 million, according to Benzinga Pro....
Newsmax Q2 Net Loss Widens, Revenue Increases
Newsmax Q2 Net Loss Widens, Revenue Increases
Aug 20, 2025
05:04 PM EDT, 08/19/2025 (MT Newswires) -- Newsmax ( NMAX ) reported a Q2 net loss late Tuesday of $0.59 per diluted share, wider than a loss of $0.15 a year earlier. One analyst expected a loss of $0.02 in a FactSet poll. Revenue for the quarter ended June 30 was $46.4 million, up from $39.2 million a year earlier....
Celldex Discontinues Barzolvolimab Development in Eosinophilic Esophagitis; Shares Fall After Hours
Celldex Discontinues Barzolvolimab Development in Eosinophilic Esophagitis; Shares Fall After Hours
Aug 20, 2025
05:03 PM EDT, 08/19/2025 (MT Newswires) -- Celldex Therapeutics ( CLDX ) said Tuesday it will not advance development of barzolvolimab in eosinophilic esophagitis after topline results from a phase 2 study showed the drug met its primary endpoint, but the mast cell depletion observed did not result in clinical improvement. The trial met the primary endpoint of absolute change...
Quest Diagnostics Insider Sold Shares Worth $355,500, According to a Recent SEC Filing
Quest Diagnostics Insider Sold Shares Worth $355,500, According to a Recent SEC Filing
Aug 20, 2025
04:57 PM EDT, 08/19/2025 (MT Newswires) -- Patrick Plewman, Senior Vice President for Diagnostic Services, on August 15, 2025, sold 1,975 shares in Quest Diagnostics ( DGX ) for $355,500. Following the Form 4 filing with the SEC, Plewman has control over a total of 17,244 common shares of the company, with 17,244 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1022079/000149736825000007/xslF345X05/wk-form4_1755636429.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved